{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:26:23Z","timestamp":1783347983179,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13343-1","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T03:46:53Z","timestamp":1778471213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hospitalization and diabetes mellitus as predictors of unfavorable tuberculosis treatment outcomes"],"prefix":"10.1186","volume":"26","author":[{"given":"Edson Beyker de","family":"Mendon\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Ara\u00fajo-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Carvalho de","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caian Leal de Azevedo","family":"Vinhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Arana Stanis","family":"Schmaltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Marinho","family":"Sant\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Moreira","family":"Ridolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno de Bezerril","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Cavalcanti","family":"Rolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"13343_CR1","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization. 2024. Available from: https:\/\/iris.who.int\/handle\/10665\/379339."},{"issue":"10","key":"13343_CR2","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1590\/S1806-37132009001000011","volume":"35","author":"MB Conde","year":"2009","unstructured":"Conde MB, Melo FAF, Marques AMC, Cardoso NC, Pinheiro VGF, Dalcin PTR, et al. III Diretrizes para Tuberculose da Sociedade Brasileira de Pneumologia e Tisiologia. J Bras Pneumol. 2009;35(10):1018\u201348. https:\/\/doi.org\/10.1590\/S1806-37132009001000011.","journal-title":"J Bras Pneumol"},{"issue":"5","key":"13343_CR3","doi-asserted-by":"publisher","first-page":"e636","DOI":"10.1016\/S2214-109X(23)00175-4","volume":"11","author":"D Chanda","year":"2023","unstructured":"Chanda D, Kasanga M, Chanda R, Cobelens F. C reactive protein: another addition to our armamentarium against tuberculosis? Lancet Glob Health. 2023;11(5):e636\u20137. https:\/\/doi.org\/10.1016\/S2214-109X(23)00175-4.","journal-title":"Lancet Glob Health"},{"issue":"7","key":"13343_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1473-3099(07)70112-3","volume":"7","author":"FM Perrin","year":"2007","unstructured":"Perrin FM, Lipman MC, McHugh TD, Gillespie SH. Biomarkers of treatment response in clinical trials of novel antituberculosis agents. Lancet Infect Dis. 2007;7(7):481\u201390. https:\/\/doi.org\/10.1016\/S1473-3099(07)70112-3.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"13343_CR5","doi-asserted-by":"publisher","first-page":"e00227","DOI":"10.1128\/cmr.00227-21","volume":"35","author":"J Heyckendorf","year":"2022","unstructured":"Heyckendorf J, Georghiou SB, Frahm N, Heinrich N, Kontsevaya I, Reimann M, et al. Tuberculosis treatment monitoring and outcome measures: new interest and new strategies. Clin Microbiol Rev. 2022;35(3):e00227\u201321. https:\/\/doi.org\/10.1128\/cmr.00227-21.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"13343_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nri2960","volume":"11","author":"G Walzl","year":"2011","unstructured":"Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Immunological biomarkers of tuberculosis. Nat Rev Immunol. 2011;11(5):343\u201354. https:\/\/doi.org\/10.1038\/nri2960.","journal-title":"Nat Rev Immunol"},{"key":"13343_CR7","doi-asserted-by":"publisher","first-page":"661934","DOI":"10.3389\/fimmu.2021.661934","volume":"12","author":"ACC Carvalho","year":"2021","unstructured":"Carvalho ACC, Amorim G, Melo MGM, Silveira AKA, Vargas PHL, Moreira ASR, et al. Pre treatment neutrophil count as a predictor of antituberculosis therapy outcomes: a multicenter prospective cohort study. Front Immunol. 2021;12:661934. https:\/\/doi.org\/10.3389\/fimmu.2021.661934.","journal-title":"Front Immunol"},{"issue":"6","key":"13343_CR8","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1183\/09031936.00140913","volume":"42","author":"DM Lowe","year":"2013","unstructured":"Lowe DM, Bandara AK, Packe GE, Barker RD, Wilkinson RJ, Griffiths CJ, et al. Neutrophilia independently predicts death in tuberculosis. Eur Respir J. 2013;42(6):1752\u20137. https:\/\/doi.org\/10.1183\/09031936.00140913.","journal-title":"Eur Respir J"},{"key":"13343_CR9","doi-asserted-by":"publisher","first-page":"49439","DOI":"10.1038\/s41598-019-49439-9","volume":"9","author":"IK Holden","year":"2019","unstructured":"Holden IK, Lillebaek T, Seersholm N, Andersen PH, Wejse C, Johansen IS. Predictors for pulmonary tuberculosis treatment outcome in Denmark 2009\u20132014. Sci Rep. 2019;9:49439. https:\/\/doi.org\/10.1038\/s41598-019-49439-9.","journal-title":"Sci Rep"},{"issue":"1","key":"13343_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4046\/trd.2012.73.1.38","volume":"73","author":"CW Kim","year":"2012","unstructured":"Kim CW, Kim SH, Lee SN, Lee SJ, Lee MK, Lee JH, et al. Risk factors related with mortality in patients with pulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2012;73(1):38\u201344. https:\/\/doi.org\/10.4046\/trd.2012.73.1.38.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"13343_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijid.2020.09.017","volume":"100","author":"C Chedid","year":"2020","unstructured":"Chedid C, Kokhreidze E, Tukvadze N, Banu S, Uddin MKM, Biswas S, et al. Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study. Int J Infect Dis. 2020;100:199\u2013206. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.017.","journal-title":"Int J Infect Dis"},{"key":"13343_CR12","doi-asserted-by":"publisher","first-page":"1177432","DOI":"10.3389\/fimmu.2023.1177432","volume":"14","author":"M Ara\u00fajo-Pereira","year":"2023","unstructured":"Ara\u00fajo-Pereira M, Schutz C, Barreto Duarte B, Barr D, Villalva Serra K, Vinhaes CL, et al. Interplay between systemic inflammation, anemia, and mycobacterial dissemination and its impact on mortality in TB associated HIV: a prospective cohort study. Front Immunol. 2023;14:1177432. https:\/\/doi.org\/10.3389\/fimmu.2023.1177432.","journal-title":"Front Immunol"},{"issue":"5","key":"13343_CR13","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.21037\/jtd.2018.04.139","volume":"10","author":"J Lee","year":"2018","unstructured":"Lee J, Lim JK, Kim EJ, Lee DH, Kim YK, Yoo SS, et al. Comparison of clinical manifestations and treatment outcome according to age groups in adult patients with miliary tuberculosis. J Thorac Dis. 2018;10(5):2881\u20139. https:\/\/doi.org\/10.21037\/jtd.2018.04.139.","journal-title":"J Thorac Dis"},{"issue":"9","key":"13343_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1258\/ijsa.2009.009093","volume":"23","author":"P Tabarsi","year":"2012","unstructured":"Tabarsi P, Chitsaz E, Moradi A, Baghaei P, Farnia P, Marjani M, et al. Treatment outcome, mortality and their predictors among HIV associated tuberculosis patients. Int J STD AIDS. 2012;23(9):e1\u20134. https:\/\/doi.org\/10.1258\/ijsa.2009.009093.","journal-title":"Int J STD AIDS"},{"issue":"7","key":"13343_CR15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1590\/S0102-311X2007000700008","volume":"23","author":"MDFPMD Albuquerque","year":"2007","unstructured":"Albuquerque MDFPMD, Ximenes RADA, Lucena Silva N, Souza WVD, Dantas AT, Dantas OMS, et al. Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cad Saude Publica. 2007;23(7):1573\u201382. https:\/\/doi.org\/10.1590\/S0102-311X2007000700008.","journal-title":"Cad Saude Publica"},{"issue":"3","key":"13343_CR16","doi-asserted-by":"publisher","first-page":"e930","DOI":"10.1093\/cid\/ciac541","volume":"76","author":"F Ridolfi","year":"2023","unstructured":"Ridolfi F, Peetluk L, Amorim G, Turner M, Figueiredo M, Cordeiro Santos M, et al. Tuberculosis treatment outcomes in Brazil: different predictors for each type of unsuccessful outcome. Clin Infect Dis. 2023;76(3):e930\u20137. https:\/\/doi.org\/10.1093\/cid\/ciac541.","journal-title":"Clin Infect Dis"},{"key":"13343_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12879-018-3019-7","volume":"18","author":"Y Wen","year":"2018","unstructured":"Wen Y, Zhang Z, Li X, Xia D, Ma J, Dong Y, et al. Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and smear negative tuberculosis patients in Anqing, China: a retrospective study. BMC Infect Dis. 2018;18:104. https:\/\/doi.org\/10.1186\/s12879-018-3019-7.","journal-title":"BMC Infect Dis"},{"key":"13343_CR18","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil. 2\u00aa ed. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2019. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_recomendacoes_controle_tuberculose_brasil_2_ed.pdf."},{"issue":"9","key":"13343_CR19","doi-asserted-by":"publisher","first-page":"e45704","DOI":"10.1371\/journal.pone.0045704","volume":"7","author":"CAS Schmaltz","year":"2012","unstructured":"Schmaltz CAS, Santoro Lopes G, Louren\u00e7o MC, Morgado MG, Velasque LDS, Rolla VC. Factors impacting early mortality in tuberculosis\/HIV patients: differences between subjects na\u00efve to and previously started on HAART. PLoS ONE. 2012;7(9):e45704. https:\/\/doi.org\/10.1371\/journal.pone.0045704.","journal-title":"PLoS ONE"},{"key":"13343_CR20","doi-asserted-by":"publisher","first-page":"e0269765","DOI":"10.1371\/journal.pone.0269765","volume":"18","author":"FM Sant\u00b4Anna","year":"2023","unstructured":"Sant\u00b4Anna FM, Ara\u00fajo-Pereira M, Schmaltz CAS, Arriaga MB, Andrade BB, Rolla VC. Impact of adverse drug reactions on the outcomes of tuberculosis treatment. PLoS ONE. 2023;18:e0269765. https:\/\/doi.org\/10.1371\/journal.pone.0269765.","journal-title":"PLoS ONE"},{"key":"13343_CR21","unstructured":"World Health Organization. Meeting report of the WHO expert consultation on drug resistant tuberculosis treatment outcome definitions, 17\u201319 November 2020. Geneva: World Health Organization. 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240022195."},{"key":"13343_CR22","unstructured":"World Health Organization. Treatment of tuberculosis guidelines. 4th ed. Geneva: World Health Organization. 2010. Available from: https:\/\/iris.who.int\/handle\/10665\/44165."},{"key":"13343_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12874-024-02392-2","volume":"24","author":"Y-H Hu","year":"2024","unstructured":"Hu Y-H, Wu R-Y, Lin Y-C, Lin T-Y. A novel MissForest-based missing values imputation approach with recursive feature elimination in medical applications. BMC Med Res Methodol. 2024;24:269. https:\/\/doi.org\/10.1186\/s12874-024-02392-2.","journal-title":"BMC Med Res Methodol"},{"key":"13343_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2334-8-72","volume":"8","author":"G Meintjes","year":"2008","unstructured":"Meintjes G, Schoeman H, Morroni C, Wilson D, Maartens G. Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross sectional study. BMC Infect Dis. 2008;8:72. https:\/\/doi.org\/10.1186\/1471-2334-8-72.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"13343_CR25","first-page":"635","volume":"2","author":"SD Lawn","year":"1998","unstructured":"Lawn SD, Afful B, Acheampong JW. Pulmonary tuberculosis: diagnostic delay in Ghanaian adults. Int J Tuberc Lung Dis. 1998;2(8):635\u201340.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13343_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40249-021-00879-4","volume":"10","author":"B Kirubi","year":"2021","unstructured":"Kirubi B, Ong\u2019ang\u2019o J, Nguhiu P, L\u00f6nnroth K, Rono A, Annerstedt KS. Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya. Infect Dis Poverty. 2021;10:95. https:\/\/doi.org\/10.1186\/s40249-021-00879-4.","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"13343_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1590\/S0104-11692013000200006","volume":"21","author":"NFD Oliveira","year":"2013","unstructured":"Oliveira NFD, Gon\u00e7alves MJF. Social and environmental factors associated with the hospitalization of tuberculosis patients. Rev Latino-Am Enfermagem. 2013;21(2):507\u201314. https:\/\/doi.org\/10.1590\/S0104-11692013000200006.","journal-title":"Rev Latino-Am Enfermagem"},{"issue":"5","key":"13343_CR28","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1378\/chest.114.5.1244","volume":"114","author":"VK Rao","year":"1998","unstructured":"Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest. 1998;114(5):1244\u201352. https:\/\/doi.org\/10.1378\/chest.114.5.1244.","journal-title":"Chest"},{"issue":"9","key":"13343_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.5588\/ijtld.18.0617","volume":"23","author":"MA Galego","year":"2019","unstructured":"Galego MA, Santos JV, Viana J, Freitas A, Duarte R. To be or not to be hospitalised with tuberculosis in Portugal. Int J Tuberc Lung Dis. 2019;23(9):1029\u201334. https:\/\/doi.org\/10.5588\/ijtld.18.0617.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"13343_CR30","first-page":"931","volume":"4","author":"Z Taylor","year":"2000","unstructured":"Taylor Z, Marks SM, R\u00edos Burrows NM, Weis SE, Stricof RL, Miller B. Causes and costs of hospitalization of tuberculosis patients in the United States. Int J Tuberc Lung Dis. 2000;4(10):931\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"13343_CR31","doi-asserted-by":"publisher","first-page":"e0203437","DOI":"10.1371\/journal.pone.0203437","volume":"13","author":"M Raberahona","year":"2018","unstructured":"Raberahona M, Razafinambinintsoa T, Andriananja V, Ravololomanana N, Tongavelona J, Rakotomalala R, et al. Hospitalization of HIV-positive patients in a referral tertiary care hospital in Antananarivo, Madagascar, 2010\u20132016: trends, causes and outcome. PLoS ONE. 2018;13(8):e0203437. https:\/\/doi.org\/10.1371\/journal.pone.0203437.","journal-title":"PLoS ONE"},{"issue":"4","key":"13343_CR32","doi-asserted-by":"publisher","first-page":"977","DOI":"10.4314\/ahs.v13i4.17","volume":"13","author":"A Namutebi","year":"2013","unstructured":"Namutebi A, Kamya M, Byakika-Kibwika P. Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago Hospital, Uganda. Afr Health Sci. 2013;13(4):977\u201385. https:\/\/doi.org\/10.4314\/ahs.v13i4.17.","journal-title":"Afr Health Sci"},{"issue":"6","key":"13343_CR33","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.4269\/ajtmh.21-0133","volume":"105","author":"PG Beckwith","year":"2021","unstructured":"Beckwith PG, Tlali M, Charalambous S, Churchyard GJ, Fielding KL, Hoffmann CJ, et al. Causes and outcomes of admission and investigation of tuberculosis in adults with advanced HIV in South African hospitals: data from the TB Fast Track trial. Am J Trop Med Hyg. 2021;105(6):1662\u201371. https:\/\/doi.org\/10.4269\/ajtmh.21-0133.","journal-title":"Am J Trop Med Hyg"},{"key":"13343_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12890-018-0628-2","volume":"18","author":"A Asres","year":"2018","unstructured":"Asres A, Jerene D, Deressa W. Delays to treatment initiation is associated with tuberculosis treatment outcomes among patients on directly observed treatment short course in Southwest Ethiopia: a follow-up study. BMC Pulm Med. 2018;18:64. https:\/\/doi.org\/10.1186\/s12890-018-0628-2.","journal-title":"BMC Pulm Med"},{"key":"13343_CR35","unstructured":"World Health Organization. The global diabetes compact \u2013 progress in supporting its workstreams: technical report. Geneva: World Health Organization. 2024. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240103092."},{"issue":"4","key":"13343_CR36","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1016\/S2214-109X(18)30487-X","volume":"7","author":"JJ Noubiap","year":"2019","unstructured":"Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2.3 million patients with tuberculosis. Lancet Glob Health. 2019;7(4):e448\u201360. https:\/\/doi.org\/10.1016\/S2214-109X(18)30487-X.","journal-title":"Lancet Glob Health"},{"issue":"8","key":"13343_CR37","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/infdis\/jiab427","volume":"224","author":"MB Arriaga","year":"2021","unstructured":"Arriaga MB, Ara\u00fajo-Pereira M, Barreto-Duarte B, Nogueira B, Freire MVCNS, Queiroz ATL, et al. The effect of diabetes and prediabetes on antituberculosis treatment outcomes: a multicenter prospective cohort study. J Infect Dis. 2021;224(8):1364\u201374. https:\/\/doi.org\/10.1093\/infdis\/jiab427.","journal-title":"J Infect Dis"},{"issue":"7","key":"13343_CR38","doi-asserted-by":"publisher","first-page":"783","DOI":"10.5588\/ijtld.18.0433","volume":"23","author":"P Huangfu","year":"2019","unstructured":"Huangfu P, Ugarte-Gil C, Golub J, Pearson F, Critchley J. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2019;23(7):783\u201396. https:\/\/doi.org\/10.5588\/ijtld.18.0433.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"13343_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00038-019-01277-2","volume":"65","author":"S Sahakyan","year":"2020","unstructured":"Sahakyan S, Petrosyan V, Abrahamyan L. Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: a cohort study. Int J Public Health. 2020;65(1):37\u201343. https:\/\/doi.org\/10.1007\/s00038-019-01277-2.","journal-title":"Int J Public Health"},{"issue":"7","key":"13343_CR40","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1086\/507543","volume":"43","author":"HMJ Nijland","year":"2006","unstructured":"Nijland HMJ, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, Nelwan RHH, et al. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis. 2006;43(7):848\u201354. https:\/\/doi.org\/10.1086\/507543.","journal-title":"Clin Infect Dis"},{"key":"13343_CR41","doi-asserted-by":"publisher","first-page":"107140","DOI":"10.1016\/j.ijid.2024.107140","volume":"146","author":"AA Boadu","year":"2024","unstructured":"Boadu AA, Yeboah-Manu M, Osei-Wusu S, Yeboah-Manu D. Tuberculosis and diabetes mellitus: the complexity of the comorbid interactions. Int J Infect Dis. 2024;146:107140. https:\/\/doi.org\/10.1016\/j.ijid.2024.107140.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"13343_CR42","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","volume":"42","author":"M Niemi","year":"2003","unstructured":"Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivist\u00f6 KT. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet. 2003;42(9):819\u201350. https:\/\/doi.org\/10.2165\/00003088-200342090-00003.","journal-title":"Clin Pharmacokinet"},{"key":"13343_CR43","doi-asserted-by":"publisher","first-page":"e53948","DOI":"10.2196\/53948","volume":"10","author":"L Zhao","year":"2024","unstructured":"Zhao L, Gao F, Zheng C, Sun X. The impact of optimal glycemic control on tuberculosis treatment outcomes in patients with diabetes mellitus: systematic review and meta-analysis. JMIR Public Health Surveill. 2024;10:e53948. https:\/\/doi.org\/10.2196\/53948.","journal-title":"JMIR Public Health Surveill"},{"issue":"12","key":"13343_CR44","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.5588\/ijtld.18.0340","volume":"22","author":"R Van Crevel","year":"2018","unstructured":"Van Crevel R, Koesoemadinata R, Hill PC, Harries AD. Clinical management of combined tuberculosis and diabetes. Int J Tuberc Lung Dis. 2018;22(12):1404\u201310. https:\/\/doi.org\/10.5588\/ijtld.18.0340.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13343_CR45","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s12879-016-1997-x","volume":"16","author":"LA Ronald","year":"2016","unstructured":"Ronald LA, FitzGerald JM, Benedetti A, Boivin J-F, Schwartzman K, Bartlett-Esquilant G, Menzies D. Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study. BMC Infect Dis. 2016;16:679. https:\/\/doi.org\/10.1186\/s12879-016-1997-x.","journal-title":"BMC Infect Dis"},{"key":"13343_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MD.0b013e318030b605","volume":"86","author":"JY Wang","year":"2007","unstructured":"Wang JY, Hsueh P-R, Wang S-K, Jan I-S, Lee L-N, Liaw Y-S, Yang P-C, Luh K-T. Disseminated Tuberculosis: A 10-Year Experience in a Medical Center. Medicine. 2007;86:39\u201346. https:\/\/doi.org\/10.1097\/MD.0b013e318030b605.","journal-title":"Medicine"},{"key":"13343_CR47","doi-asserted-by":"publisher","first-page":"e90614","DOI":"10.1371\/journal.pone.0090614","volume":"9","author":"BJ Kirenga","year":"2014","unstructured":"Kirenga BJ, Levin J, Ayakaka I, Worodria W, Reilly N, Mumbowa F, Nabanjja H, Nyakoojo G, Fennelly K, Nakubulwa S, et al. Treatment Outcomes of New Tuberculosis Patients Hospitalized in Kampala, Uganda: A Prospective Cohort Study. PLoS ONE. 2014;9:e90614. https:\/\/doi.org\/10.1371\/journal.pone.0090614.","journal-title":"PLoS ONE"},{"key":"13343_CR48","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1038\/s41598-018-25409-5","volume":"8","author":"CPB De Almeida","year":"2018","unstructured":"De Almeida CPB, Ziegelmann PK, Couban R, Wang L, Busse JW, Silva DR. Predictors of In-Hospital Mortality among Patients with Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. Sci Rep. 2018;8:7230. https:\/\/doi.org\/10.1038\/s41598-018-25409-5.","journal-title":"Sci Rep"},{"key":"13343_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cmi.2021.07.011","volume":"28","author":"A Takamatsu","year":"2022","unstructured":"Takamatsu A, Kano Y, Tagashira Y, Kirikae T, Honda H. Current in-hospital management for patients with tuberculosis in a high-income country: a retrospective cohort study. Clin Microbiol Infect. 2022;28:383\u201390. https:\/\/doi.org\/10.1016\/j.cmi.2021.07.011.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13343-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13343-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13343-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:02:44Z","timestamp":1783346564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13343-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13343"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13343-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of INI (CAAE: 55844622.4.0000.5262) and conducted in accordance with the Declaration of Helsinki. Participants signed a consent declaration to confirm they understood the study, its risks, and their rights, and that they voluntarily agreed to take part.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the material is owned by the authors and no permissions are required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1239"}}